Alaunos Therapeutics(DE:WEK0)
€1.000.00 (0.00%)
DE:WEK0
Alaunos Therapeutics financials statements
€1.00
At close:0.00 (0.00%)
Alaunos Therapeutics (WEK0) Income Statement
0 Followers
Alaunos Therapeutics Income Statement
Last quarter (Q3 2026), Alaunos Therapeutics's total revenue was $0.00. In Q3, Alaunos Therapeutics's net income was $-772.00K. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 5.00K | $ 10.00K | $ 5.00K | $ 2.92M | $ 398.00K | |
| $ -1.36M | $ -352.00K | $ -4.80M | $ -19.60M | $ -46.88M | |
| $ 2.87M | $ 4.46M | $ 29.47M | $ 15.51M | $ 30.67M | |
| Depreciation and Amortization | $ 7.00K | $ 2.00K | $ 2.31M | $ 2.76M | $ 2.60M |
| $ -4.17M | $ -4.68M | $ -30.90M | $ -31.82M | $ -74.97M | |
| $ -4.22M | $ -4.81M | $ -34.27M | $ -35.10M | $ -77.55M | |
| $ 49.00K | $ 133.00K | $ -873.00K | $ -2.63M | $ -1.20M | |
| $ -4.18M | $ -4.68M | $ -35.14M | $ -37.73M | $ -78.75M | |
| $ -4.18M | $ -4.68M | $ -35.14M | $ -37.73M | $ -78.75M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.20 | $ -2.92 | $ -21.97 | $ -25.97 | $ -53.80 |
| Diluted EPS | $ -2.20 | $ -2.92 | $ -21.97 | $ -25.97 | $ -53.80 |
| Weighted Average Shares Outstanding | 1.95M | 1.60M | 1.60M | 1.45M | 1.43M |
| Weighted Average Shares Outstanding (Diluted) | 1.95M | 1.60M | 1.60M | 1.45M | 1.43M |
Currency in USD

